DoD Assays’ Clearance Goals Reveal FDA Accelerated Review Priorities
This article was originally published in The Gray Sheet
Executive Summary
FDA is assuring the Department of Defense that counterterrorism assays targeted by DoD's acquisitions program are likely priority candidates for the agency's 510(k) clearance process